Is COVID going around in Iceland?

COVID-19 surveillance in Iceland is now integrated into Landlæknir's weekly respiratory-virus monitoring. Key indicators include primary-care consultations, laboratory positivity at Landspítali, hospitalisations and ICU admissions for severe acute respiratory infection, and variant characterisation at the hospital's reference laboratory. Results are published weekly and also reported to ECDC for inclusion in ERVISS.

COVID-19 is endemic in Iceland and continues to cause winter hospitalisations, concentrated in older adults and people with chronic or immunosuppressive conditions. Vaccination and prior infections mean most adults experience an illness similar to flu or a heavy cold. Targeted booster campaigns and symptomatic monitoring have replaced general restrictions, and Landlæknir tracks the weekly picture alongside flu and RSV.

COVID-19 in Iceland has not settled into a single seasonal rhythm. Winter waves overlapping with flu and RSV are the most consistent pattern, but summer or spring upticks have occurred when immune-escape variants emerged. Because the population is small, waves can rise sharply once a new lineage establishes, making multi-week hospital-admission and positivity trends the most reliable early-warning signals.

Landlæknir recommends seasonal COVID-19 boosters primarily for adults aged 60 and above, people with pre-existing conditions, pregnant women, residents of long-term-care facilities, and healthcare workers. Vaccines are delivered through primary-care health centres at no cost for eligible groups. Landlæknir publishes uptake and virological-surveillance updates in the same weekly cycle.

Yes. Landspítali's laboratory continues to sequence SARS-CoV-2 samples from hospital and sentinel cases, and Iceland has historically been a high-sequencing country relative to its size. Most emerging lineages cause illness comparable to their predecessors, but variants with substantial immune escape can drive larger waves. Icelandic variant-trend reports feed into ECDC ERVISS for EU/EEA-wide context.